Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Tislelizumab in Combination With Chemotherapy for Gastric, Gastrosophageal Junction Adenocarcinoma - 4 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 7 months ago FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 7 months ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 8 months ago Bulevirtide in Combination With PegInterferon Results In Undetectable Hepatitis D RNA Post-Treatment - 10 months ago Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 10 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 10 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 12 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - about 1 year ago Study: Belumosudil Decreased Collagen, IL-17 Levels for Skin, Oral cGVHD - about 1 year ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - about 1 year ago Investigational GLP-1 Medication Found to Reduce Body Weight - about 1 year ago FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer - about 1 year ago FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma - about 1 year ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - about 1 year ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - over 1 year ago Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura - over 1 year ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - over 1 year ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - over 1 year ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 7 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	iOnctura achieves new clinical milestones in uveal melanoma therapy - 4 months ago Poolbeg Pharma presents positive results for POLB 001 - 4 months ago Pharma giants vie for oral GLP-1R approval - 5 months ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 11 months ago Poolbeg’s cytokine release syndrome drug shows potential - over 1 year ago
4	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 5 months ago
5	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	IG Live December 2: The Weight of Wegovy - 5 months ago
6	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy - 6 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - about 1 year ago Adagrasib Meets Primary Endpoint Among Individuals with KRAS G12C-Mutated Locally Advanced or Metastatic NSCLC - about 1 year ago J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis - about 1 year ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer - 6 months ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - 6 months ago Can you get satiety with GLP-1s without the nausea? - 9 months ago
9	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 8 months ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Ozempic and Wegovy linked to lower risk of alcoholism - 10 months ago

Journalists covering rogolisib